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.2013.01.0Abstract Nanoparticles (NPs) offer a great possibility for biomedical application, not only to deli-
ver pharmaceutics, but also to be used as novel diagnostic and therapeutic approaches. Currently,
there are no data available regarding to what extent the degree of the toxicity and the accumulation
of gold nanoparticles (GNPs) are present in in vivo administration. This study aimed to address the
GNP size and exposure duration effect on the liver and kidney function of rats: in vivo.
Methods: A total of 30 healthymaleWistar-Kyoto rats of the same age (12 weeks old) and weighing
220–240 g ofKing SaudUniversity colonywere used. Animals were randomly divided into groups, two
GNP-treated rat groups and one control group (CG). The 50 ll of 10 and 50 nm GNPs was intraperi-
toneally administered in rats for exposure duration of 3 days. Then, several biochemical parameters
such as aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alanine transaminase
(ALT), alkaline phosphatase (ALP), urea (UREA) and creatinine (CREA) were evaluated.
Results: In this study, theAST values increasedwith the administration of 10 and 50 nmGNPs com-
pared with the control. The AST values signiﬁcantly increased with 10 nmGNPs comparedwith 50 nm
GNPsand control. TheGGTandALTvalues decreasedwith the administrationof 10 and 50 nmGNPs
compared with the control. The GGT and ALT values signiﬁcantly decreased with 50 nm GNPs com-
paredwith 10 nmGNPs and control. TheALP values signiﬁcantly decreasedwith the administration of
10 and 50 nm GNPs compared with the control. The decrease in ALP values with 10 nm GNPs was
higher than those compared with 50 nm GNPs. In this study, the levels of UREA and CREA values
increased in a non signiﬁcant manner after the administration of 10 and 50 nm GNPs compared with
the control.Department of Physics and
Saud University, P.O. 2455,
6 14676451.
yahoo.com, mabdulhleem
herifmoussa96 @yahoo.com
Saud University.
g by Elsevier
ing by Elsevier B.V. on behalf of King Saud University.
07
178 M.A.K. Abdelhalim, S.A. Abdelmottaleb MoussaConclusions: This study demonstrates that the increase in the enzymesAST and the decrease inALP
are smaller GNPs (10 nm) size-dependent for exposure duration of 3 days; while the decrease in the
enzymesGGT andALT are biggerGNPs (50 nm) size-dependent. The levels ofUREA andCREAval-
ues indicated no signiﬁcant changes with the administration of 10 and 50 nmGNPs for exposure dura-
tion of 3 days comparedwith the control. The administration of 10 and 50 nmGNPs for short exposure
duration of 3 days induced only signiﬁcant variations with some liver enzymes while kidney showed no
signiﬁcant variations. This study suggests that synthesis and metabolism of GNPs as well as the protec-
tion of the liver will be more important issues for medical applications of gold-based nanomaterials in
future.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The rats exposed to gold nanoparticles (GNPs) revealed that
the GNPs were rapidly taken into the system with the highest
accumulation in the lungs and aorta (Lanone and Boczkowski,
2006). Moreover, GNPs are believed to be more biologically
reactive than their bulk material due to their small size and lar-
ger surface area to volume ratio (Lanone and Boczkowski,
2006; Yu et al., 2007).
Although some scientists consider NPs as nontoxic, other
studies reported the toxic effects of NPs (Chithrani and Chan,
2007; Pan et al., 2007; BarathManiKanth et al., 2010). The
toxicity of NPs is being addressed by a number of standardized
approaches with in vitro, in vivo as well as detailed genomic or
biodistribution studies (Schrand et al., 2008). In addition,
GNPs are used as carriers for drug delivery and genes (Gibson
et al., 2007).
The GNPs imply that they could get close to a biological
target of interest. The environmental impact of NPs is evident;
however, their nanotoxicity due to the reduction in size to
nanoscale is rarely discussed. GNPs may serve as a promising
model to address this size-dependent toxicity, since gold is
extraordinarily biocompatible. There are differing reports of
the extent of the toxic nature of these particles owing to the
different modiﬁcations of GNPs, surface functional attach-
ments, shape and diameter size of the nanospheres (Takahashi
et al., 2006; Pan et al., 2007).
Abdelhalim, 2011a,b and Abdelhalim, 2012a,b; Abdelhalim
and Jarrar, 2011a,b,c,d have reported that the bioaccumula-
tion of GNPs in several rat tissues (liver, heart, kidney and
lung) is size and exposure duration dependent.
The GNP size and exposure duration effect on the liver and
kidney function of rats: in vivo have not been well documented
before. In the present study we aimed to address the
particle-size and exposure duration effect on the liver and
kidney function in an attempt to cover and understand the tox-
icity and potential therapeutic and diagnostic tool of GNPs.
2. Materials and methods
A total of 30 healthy male Wistar-Kyoto rats were obtained
from the Laboratory Animal Center (College of Pharmacy,
King Saud University, Saudi Arabia). The rats nearly of the
same age (12 weeks old) and weighing 220–240 g of King Saud
University colony were used. Animals were randomly divided
into groups, two GNP-treated rats groups and one control
group (CG). The 10 and 50 nm GNPs were intraperitoneally
administered in rats at the rate of 3 days as follows: Group 1(G1): received infusion of 50 ll GNPs of size 10 nm for 3 days
(n= 10); Group 2 (G2): received infusion of 50 ll GNPs of
size 50 nm for 3 days (n= 10); The rats were maintained on
standard laboratory rodent diet pellets and housed in humidity
and temperature-controlled ventilated cages on a 12 h day/
night cycle. All experiments were conducted in accordance
with the guidelines approved by King Saud University Local
Animal Care and Use Committee.3. Serum biochemical analysis
Whole blood was centrifuged twice at 3000 rpm for 10 min in
order to separate serum. Using a biochemical autoanalyzer
(Type 7170, Hitachi), serum biochemical analysis was carried
out. To evaluate the liver function, the levels of aspartate
aminotransferase (AST), gamma-glutamyl transferase (GGT),
alanine transaminase (ALT) and alkaline phosphatase (ALP)
were measured; while to evaluate the kidney function, the levels
of urea (UREA) and creatinine (CREA) were measured.4. Results and discussions
For exposure duration of 3 days, the effects of intraperitoneal
administration of 10 and 50 nm of GNPs on the blood serum
of rats were evaluated through the measurement of different
biochemical parameters such as AST, GGT, ALT, ALP,
UREA and CREA.
In this study, the AST values increased with the administra-
tion of 10 (228.18 ± 43.53; Mean ± SE); and 50 (200.96 ±
21.02) nm GNPs compared with the control (180.08 ±
23.26) (Fig. 1). The AST values signiﬁcantly increased with
10 nm GNPs compared with 50 nm GNPs and control (Wim
et al., 2008). This study suggests that the liver might be slightly
damaged with the administration of GNPs, and the GNPs
have a direct effect on the liver function.
Serum AST and ALT levels are common markers for hepa-
tic toxicity: levels of these proteins are rapidly increased when
the liver is damaged by any cause, including hepatitis or hepa-
tic cirrhosis (Sheth et al., 1998).
The hepatocyte swelling might be exhibited as a result of
disturbances of membrane function that lead to a massive in-
ﬂux of water and Na+ due to GNP effects accompanied by
leakage of lysosomal hydrolytic enzymes that lead to cytoplas-
mic degeneration and macromolecular crowding (Abdelhalim,
2012a,b; Abdelhalim and Jarrar, 2011a,b,c,d).
The vacuolated swelling of the cytoplasm of the
hepatocytes of the GNP treated rats might indicate an acute
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Figure 1 The levels of aspartate transaminase (AST) versus the
gold nanoparticle size in rats’ blood serum.
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Figure 2 The levels of gamma glutamyl transferase (GGT)
versus the gold nanoparticle size in rats’ blood serum.
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Figure 3 The levels of alanine transferase (ALT) versus the gold
nanoparticle size in rats’ blood serum.
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tions were size-dependent with smaller ones inducing most ef-
fects and related to time exposure of GNPs (Abdelhalim,
2012a,b; Abdelhalim and Jarrar, 2011a,b,c,d).
For 13 nm sized colloidal gold beads, the highest amount of
gold was observed in liver and spleen after intraperitoneal
administration (Hillyer and Albrecht, 1999). In another study,
intravenously injected gold nanorods (65 ± 5 nm) revealed
that within minutes these particles accumulated predominantly
in the liver (Niidome et al., 2006).
At exposure duration of 3 days, the GGT values decreased
with the administration of 10 (14.8 ± 1.36; Mean ± SE) and
50 (10.2 ± 1.36) nm GNPs compared with the control
(15.8 ± 1.74). The GGT values signiﬁcantly decreased with
50 nm GNPs compared with 10 nm GNPs and control
(Fig. 2). The ALT values decreased with the administration
of 10 (65.86 ± 6.01; Mean ± SE) and 50 (60.38 ± 7.42) nm
GNPs for exposure duration of 3 days compared with the
control (70.52 ± 10.09). The ALT values signiﬁcantly de-
creased with 50 nm GNPs compared with 10 nm GNPs and
control (Fig. 3).
The ALP values signiﬁcantly decreased with the administra-
tion of 10 (196.60 ± 33.95; Mean ± SE) and 50
(251.60 ± 38.52) nm GNPs compared with the control
(347 ± 52.52). The decrease in ALP values with 10 nm GNPs
was higher than those with 50 nm GNPs (Fig. 4).
In this study, the levels of UREA values increased in a non
signiﬁcant manner after the administration of 10
(43.56 ± 1.68; Mean ± SE) and 50 (44.18 ± 2.59) nm GNPs
compared with the control (38.36 ± 3.36) (Fig. 5). In this
study, the levels of CREA values increased in a non signiﬁcant
manner after the administration of 10 (0.284 ± 0.02;
Mean ± SE) and 50 (0.294 ± 0.05) nm GNPs compared with
the control (0.274 ± 0.06) (Fig. 6). The non signiﬁcant changes
observed in the levels of UREA and CREA might beattributed to the highest clearance of GNPs through the
kidney and/or less exposure duration of GNPs.
In kidney, there was a signiﬁcant increase in the amount of
gold after repeated injection of GNPs. Interestingly the% gold
accumulated decreases when the GNP dose increases, suggest-
ing an efﬁcient clearance of GNPs from the body (Lasagna-
Reeves et al., 2010).
The levels of UREA, CREA, total bilirubin and ALP in
rats’ blood serum were tested as a measure of kidney, hepatic
and biliary functionality. A detailed analysis of all these
metabolites in serum of animals treated with different doses
of GNPs as compared to controls showed no statistically
signiﬁcant differences in any of the parameters tested
(Lasagna-Reeves et al., 2010).
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Figure 4 The levels of alkaline phosphatase (ALP) versus the
gold nanoparticle size in rats’ blood serum.
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Figure 5 The levels of urea (UREA) versus the gold nanoparticle
size in rats’ blood serum.
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Fig. 6 The levels of creatinine (CREA) versus the gold nano-
particlesize in rats’ blood serum.
180 M.A.K. Abdelhalim, S.A. Abdelmottaleb MoussaAfter absorption of GNP following, e.g. inhalation, oral or
dermal exposure, further distribution in the body then occurs
via the blood circulation. The distribution of GNPs proved
to depend on the size and exposure duration of the injected
particles. The smallest GNPs revealed the most widespread tis-
sue distribution at 3 days after injection (Abdelhalim, 2011a,b;
Abdelhalim, 2012a,b; Abdelhalim and Jarrar, 2011a,b,c,d;
Wim et al., 2008).
Exposure to GNP doses produced cloudy swelling, vacuo-
lar degeneration, hyaline droplets and casts, karyorrhexis
and karyolysis. The glomeruli showed moderate congestionwith no hypercellularity or basement membrane thickening.
These changes were mainly seen in the cortex and the proximal
renal convoluted tubules than the distal ones. Moreover,
cloudy swelling, renal tubular necrosis and intertubular blood
capillary dilatation and hemorrhage, and inﬂammatory cell
inﬁltrations were observed (Abdelhalim and Jarrar,
2011a,b,c,d).
This study suggests that synthesis and metabolism of differ-
ent GNP sizes as well as protection of the liver will be more
important issues for medical applications of gold-based
nanomaterials in future. Therefore, further kinetic and toxic-
okinetic studies are required to extend the existing knowledge
on particle behavior in vivo.5. Conclusions
This study aimed to address the GNP size and exposure dura-
tion effects of GNPs on the liver and kidney function of rats:
in vivo.
A total of 30 healthy male Wistar-Kyoto rats of the same
age (12 weeks old) and weighing 220–240 g of King Saud Uni-
versity colony were used in this study. Several biochemical
parameters such as AST, GGT, ALT, ALP, UREA and
CREA were evaluated.
This study demonstrates that for exposure duration of
3 days, the increase in the enzymes AST and the decrease in
ALP are smaller GNPs (10 nm) size-dependent; while the de-
crease in the enzymes GGT and ALT are bigger GNPs
(50 nm) size-dependent. The administration of 10 and 50 nm
GNPs for short exposure duration of 3 days induced only sig-
niﬁcant variations with some liver enzymes; while the levels of
UREA and CREA values indicated no signiﬁcant changes
with the administration of GNPs for exposure duration of
3 days compared with the control.
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